Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1KAI-CHANG ZHU, Jiaju Lv|Oncology Letters|2015Cited by 30